Repair & Recovery Peptides

BPC-157 / TB-500 Refill 10mg

£40.00

BPC-157 / TB-500 Refill 10mg — lyophilised refill-cartridge research listing, 10mg combined nominal BPC-157 / TB-500 blend (individual amounts unconfirmed for this presentation). Compare adjacent formats, actual scientific evidence and product-specific batch documentation. For laboratory research only; not for human or veterinary use.

Description

BPC-157 / TB-500 Refill 10mg is a Core Research catalogue product with 10mg combined nominal BPC-157 / TB-500 blend (individual amounts unconfirmed for this presentation) supplied in a sealed refill-cartridge presentation with lyophilised research material. This page describes the exact listing, its relation to alternative formats, the experimental literature on the named material and what batch or finished-format documentation can establish. It is supplied for laboratory research only, not for human or veterinary use.

What is actually supplied?

Attribute This product
Catalogue name BPC-157 / TB-500 Refill 10mg
Named material BPC-157 and TB-500
Labelled amount 10mg combined nominal BPC-157 / TB-500 blend (individual amounts unconfirmed for this presentation)
Presentation Sealed refill-cartridge presentation with lyophilised research material
Purchase price and availability Current live WooCommerce purchase panel
Documentation route BPC-157 / TB-500 Refill 10mg — batch-documentation enquiry

The nominal 10mg is a combined quantity for two named constituents, not 10mg of each. The currently inspected pen/refill record does not independently confirm a 5mg + 5mg breakdown for this format. The separate blend-vial record does make that declaration; it must not be copied into this presentation without its own specification.

This is the separately listed refill cartridge, not a standard vial or an automatically included reusable pen housing. Its hardware compatibility and any required accessories need confirmation against the particular dispensing system and the item being purchased.

Which presentation is the right catalogue item?

A refill changes the supplied container/format; it does not automatically show that the refill has the same chemical form, stability, analytical coverage or compatibility as a vial or a pen-format listing.

Related product What is different?
BPC-157 / TB-500 Blend 10mg vial Co-lyophilised vial; expressly declared 5mg + 5mg on that listing
BPC-157 / TB-500 Blend 10mg Pen Separate preloaded pen-format product
BPC-157 Refill 10mg BPC-157-only refill

The distinction is practical rather than a claimed difference in biological activity. Compare the exact material, labelled amount, supplied container and documented finished format. The vial-versus-pen format guide explains why a common compound name does not establish matching formulation or hardware compatibility.

Why researchers investigate BPC-157 and TB-500

The studies here explain what was measured in specific preparations and experimental systems. They are compound-level evidence, not quality-control testing or performance trials for the supplied refill cartridge. For the detailed research discussion, see the BPC-157 / TB-500 blend vial research dossier.

BPC-157 constituent evidence

In rat tendon explants and fibroblasts, BPC-157 was associated with greater cell migration, spreading and survival under oxidative stress, but not a direct proliferation increase in the tested assay. FAK/paxillin findings concerned attachment-related signalling. Separately, endothelial and rat vascular experiments investigated VEGFR2 expression, trafficking and vessel-related endpoints. None of these papers tested the commercial mixture or filled device on this page. 1 2

TB-500 constituent identity and evidence

The TB-500 name covers an important identity ambiguity. Esposito and colleagues identified Ac-LKKTETQ, an acetylated thymosin-beta-4 fragment, in one marketed preparation. Other studies investigate full-length thymosin beta-4 or unacetylated fragments. Animal repair-model results for a particular fragment cannot automatically be assigned to an unspecified TB-500 constituent in a blend. 3 4

In a more recent screen, a TB-500 metabolite showed a significant response where the parent material did not show the same significant result. This is a reason to identify the actual form and analytical scope before interpreting literature or a blend’s reported composition. 5

What about research on both names together?

A 2021 uncontrolled retrospective knee-pain report included four participants who had received BPC-157 alongside material described as TB4. Three reported improvement, but there was no randomised comparator or objective functional assessment capable of establishing synergy. The material identity and formulation were not established as equivalent to the current Core Research blend format. 6

A useful controlled combination study would specify both materials and compare them individually and together using the same endpoint. The presence of two named compounds alone does not establish additive effects, synergy or a validated ratio for the supplied refill or pen.

How to check evidence for this exact refill

The most useful document identifies the tested sample, actual product, relevant format and lot. Ask whether a document covers source peptide, a filled cartridge, a two-component preparation (where relevant), or the item that would actually be dispatched. Each scope can answer different questions.

A finished two-component preparation requires component-specific identity and content evidence. A total label or one aggregate HPLC percentage cannot separately establish the actual amount of BPC-157 and TB-500, nor the TB-500 species. A raw-material report does not necessarily test the co-formulated cartridge.

What you need to know Relevant evidence or question
Named molecular identity Does the sequence, form and analytical assignment match this product?
Nominal amount versus content Is the quantity only a label declaration or also supported by a calibrated content assay?
Purity Which separation method and reporting basis were used?
Product/lot traceability Does the report match the supplied material, lot and presentation?
Finished format Is cartridge condition, container compatibility or performance separately documented where claimed?

You may ask for documentation before ordering using Batch Documentation. Include the exact name BPC-157 / TB-500 Refill 10mg, state that your enquiry is before purchase and describe what your laboratory needs. After delivery, include the container lot and order number. A report for another lot or product format must not be substituted for the record of the item supplied.

The CoA-reading guide, HPLC interpretation guide, and mass-spectrometry guide explain the limits of the individual methods. The existence of these guides is not evidence that every particular test was performed for this product.

Storage, dispatch and receiving

Use the actual product label and lot-applicable documented conditions for unopened storage, transit excursions and any laboratory preparation. The material reviewed does not establish a universal temperature, fixed expiry, freeze-thaw allowance or solution stability interval for this particular product.

A sealed refill cartridge is not automatically equivalent to a vial. Check the supplied container and closure on receipt. Compatibility with a pen housing, adapter or existing hardware must be verified for the exact product; no universal interchangeability is established by the word refill.

At delivery, compare the item name, nominal amount, packaging and lot with the order. Record any mismatch before using the material. The receiving-inspection checklist, storage-temperature guide, vial/pen comparison and warm/delayed-delivery guide provide the corresponding supporting checks.

Core Research publishes dispatch from Birmingham, United Kingdom, and plain outer packaging. Actual delivery charges and estimates vary by order and destination: consult Shipping & Delivery and the checkout’s available options. No unconditional next-day service is promised here.

Frequently asked product questions

Does this refill include a complete reusable pen?

This is a separately listed refill cartridge, not a promise that a complete reusable device body or accessories are included. Check the exact inclusions and compatibility with Core Research before buying.

Is it compatible with any peptide pen?

No universal compatibility is established. Verify the relevant housing/cartridge system and the supplier’s exact specification; matching molecule names do not demonstrate compatible hardware.

Does the 10mg blend contain 10mg of each peptide?

No. The present item is labelled as 10mg combined material. Its component-by-component amounts have not been independently established for this particular pen/refill listing; do not assume the separate vial’s 5mg + 5mg declaration automatically applies.

Can I get the batch report before purchasing?

You can submit a pre-purchase documentation enquiry by naming this exact product and the information needed. Confirm which lot/presentation the available report covers; the request route does not guarantee that every type of test has been completed.

What happens if the shipment arrives damaged or unusually warm?

Retain the parcel and order details, photograph the condition before using the material, and contact Core Research promptly with tracking and available lot information. Use the arrival-condition guide to document the concern.

Ordering and support

The live product purchase panel is the source for current price, stock status, quantity and basket action. If your decision requires a confirmed specification, included components, available testing report or compatible device, contact Core Research product support first with the exact product title. Use Batch Documentation for pre-purchase or received-lot records. The quality-testing methodology, delivery terms and research-use policy give the relevant service context.

For laboratory research only; not for human or veterinary use. Experimental cell, animal and early human observations are not a personal-use or therapeutic protocol for this supplied item.

Selected research references

[1] Chang et al. (2011). BPC-157 tendon-cell migration, survival and FAK/paxillin experiments. Journal of Applied Physiology.

[2] Hsieh et al. (2017). BPC-157 endothelial VEGFR2 experiments and animal vascular models. Journal of Molecular Medicine.

[3] Esposito et al. (2012). Analytical identification of an acetylated thymosin-beta-4 17–23 fragment in a TB-500-marketed sample. Drug Testing and Analysis.

[4] Philp et al. (2003). Thymosin-beta-4 and actin-domain fragment in animal dermal-wound models. Wound Repair and Regeneration.

[5] Rahaman et al. (2024). TB-500 and selected metabolite quantification with different fibroblast screening responses. Journal of Chromatography B.

[6] Lee and Padgett (2021). Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Alternative Therapies in Health and Medicine.

Additional information

Format

Refill cartridge

Strength

10mg